Evidence map›Paper›PMID 39976094›Full record

ReviewCurrent neuropharmacology2025

Epigenetic Mechanisms in the Pathophysiology and Progression of Epilepsy: A Comprehensive Review of Experimental and Clinical Studies.

Yinchao Li, Zhengwei Su, Ke Zhao, Xianyue Liu, Shuda Chen, Xiaofeng Yang, Liemin Zhou

Abstract readReview
In one paragraph

Review in Current neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yinchao LiDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.
Zhengwei SuDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.
Ke ZhaoDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.
Xianyue LiuDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.
Shuda ChenDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.
Xiaofeng YangGuangzhou Laboratory, Guangzhou 510005, Guangdong Province, China.
Liemin ZhouDepartment of Neurology, The Seven Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, 518107, China.

Funding

National Natural Science Foundation of China 82071447, 81971202, XFY 82271492Shenzhen Municipal Science and Technology key projects of the Basic Research Program JCYJ20220818102007015
6 · The paper itself

Abstract

Epilepsy is a prevalent neurological disorder that presents with a diverse range of clinical manifestations and etiologies influenced by both genetic and environmental factors. However, traditional genetic mechanisms alone are insufficient to fully elucidate the pathogenesis of epilepsy, highlighting the increasing importance of epigenetics in epilepsy research. Several studies have demonstrated that epigenetic mechanism play a pivotal role in the development and progression of epilepsy. This review provides a comprehensive overview of epigenetic regulation and its role in epilepsy. We emphasize the specific role of epigenetic regulation, including DNA methylation, non-coding RNA, and histone modification in the epilepsy. Finally, we discuss the potential applications of epigenetic regulation in the etiology research, drug development, and personalized therapy of epilepsy, along with the technical and theoretical challenges that need to be addressed in epigenetic research. Epigenetic mechanisms have emerged as a promising avenue for understanding the pathogenesis and treatment of epilepsy. However, to thoroughly grasp its potential implications for the clinical management of this disease, a deeper understanding of the role of epigenetics in TLE is essential. Therefore, further research is required to elucidate the specific epigenetic mechanisms involved in epilepsy, their interactions with other disease-related factors, and their potential as therapeutic targets. Such research could ultimately lead to the development of novel epigenetic-based therapies for epilepsy and other related neurological disorders.

Indexed as

Epigenesis, GeneticEpilepsyAnimalsDisease ProgressionDNA MethylationHumansDNA methylationepigenetic regulationEpilepsyhistone modificationnon-coding RNARNA modifications.

Identifiers

PMID39976094
PMCPMC12272096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.